These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31602376)

  • 1. Hepatocellular Carcinoma of Fibrolamellar Type in an Adolescent: Case Report and Literature Review.
    Santiago-Reynoso J; Zamaripa-Martínez KS; Dorantes-Loya JM; Gaytán-Fernández GJ; Apolinar-Jiménez E; Paz-Gómez F; Farias-Serratos F; Maldonado-Vega M
    Gastrointest Tumors; 2019 Aug; 6(1-2):43-50. PubMed ID: 31602376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation.
    Surjan RC; Dos Santos ES; Basseres T; Makdissi FF; Machado MA
    Am J Case Rep; 2017 Mar; 18():234-241. PubMed ID: 28270654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Basis of Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma.
    Surjan RCT; de Lima TM; de Souza HP; Machado MCC; Ardengh JC
    Cureus; 2023 Jan; 15(1):e33750. PubMed ID: 36788919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperammonemic encephalopathy and fibrolamellar hepatocellular carcinoma].
    Berger C; Dimant P; Hermida L; Paulin F; Pereyra M; Tejo M
    Medicina (B Aires); 2012; 72(5):425-7. PubMed ID: 23089120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [76-year-old patient with adenocarcinoma of the rectum and fibrolamellar hepatocellular 2d carcinoma. Case report with literature review of hepatocellular carcinoma of the fibrolamellar type].
    Klimpfinger M; Jatzko G; Trink A; Samec HJ; Gaugg A
    Wien Klin Wochenschr; 1987 Jul; 99(14):505-9. PubMed ID: 2820156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
    Lee JS; Jin HY; Ko JM; Kim SH; Han N; Park BK; Park M; Park HJ; Lee JA
    Cancer Res Treat; 2021 Jan; 53(1):283-288. PubMed ID: 32898940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperammonemic encephalopathy in a patient with fibrolamellar hepatocellular carcinoma: case report and literature review.
    Cho J; Chen JCY; Paludo J; Conboy EE; Lanpher BC; Alberts SR; Halfdanarson TR
    J Gastrointest Oncol; 2019 Jun; 10(3):582-588. PubMed ID: 31183212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrolamellar hepatocellular carcinoma in children and adolescents.
    Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
    Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.
    Chapuy CI; Sahai I; Sharma R; Zhu AX; Kozyreva ON
    Oncologist; 2016 Apr; 21(4):514-20. PubMed ID: 26975868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperammonemic encephalopathy: a rare presentation of fibrolamellar hepatocellular carcinoma.
    Sethi S; Tageja N; Singh J; Arabi H; Dave M; Badheka A; Revankar S
    Am J Med Sci; 2009 Dec; 338(6):522-4. PubMed ID: 20010160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history.
    Epstein BE; Pajak TF; Haulk TL; Herpst JM; Order SE; Abrams RA
    Am J Clin Oncol; 1999 Feb; 22(1):22-8. PubMed ID: 10025374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Diagnosis and Treatment in a Case of Fibrolamellar Carcinoma.
    Bacinschi X; Zgura AF; Mercan-Stanciu A; Grasu M; Herlea V; Toma L; Dodot M; Martiniuc A; Anghel R; Haineala B
    Cancer Diagn Progn; 2021; 1(1):23-28. PubMed ID: 35399695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful treatment of combined intraarterial (5-fluorouracil and adriamycin and cisplatin) infusion chemotherapy for advanced hepatocellular carcinoma with multiple intrahepatic metastases and/or portal vein thrombosis--two case reports].
    Kato H; Nagano H; Ota H; Nakamura M; Wada H; Yoshioka S; Noda T; Bazarragchaa D; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Murakami T; Nakamura H; Monden M
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1842-5. PubMed ID: 16315958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases.
    Chagas AL; Kikuchi L; Herman P; Alencar RS; Tani CM; Diniz MA; Pugliese V; Rocha Mde S; D'Albuquerque LA; Carrilho FJ; Alves VA
    Clinics (Sao Paulo); 2015 Mar; 70(3):207-13. PubMed ID: 26017653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.
    Kelley RK; Rimassa L; Cheng AL; Kaseb A; Qin S; Zhu AX; Chan SL; Melkadze T; Sukeepaisarnjaroen W; Breder V; Verset G; Gane E; Borbath I; Rangel JDG; Ryoo BY; Makharadze T; Merle P; Benzaghou F; Banerjee K; Hazra S; Fawcett J; Yau T
    Lancet Oncol; 2022 Aug; 23(8):995-1008. PubMed ID: 35798016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors.
    Ward SC; Waxman S
    Semin Liver Dis; 2011 Feb; 31(1):61-70. PubMed ID: 21344351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
    Weeda VB; Murawski M; McCabe AJ; Maibach R; Brugières L; Roebuck D; Fabre M; Zimmermann A; Otte JB; Sullivan M; Perilongo G; Childs M; Brock P; Zsíros J; Plaschkes J; Czauderna P; Aronson DC
    Eur J Cancer; 2013 Aug; 49(12):2698-704. PubMed ID: 23683550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Liver Transplantation for Hyperammonemic Fibrolamellar Hepatocellular Carcinoma.
    Alsina AE; Franco E; Nakshabandi A; Albers C; Kemmer N; Berry AC; Finan J
    ACG Case Rep J; 2016 Aug; 3(4):e106. PubMed ID: 27807568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrolamellar hepatocellular carcinoma: a case report.
    Khoo JJ; Clouston A
    Malays J Pathol; 2001 Dec; 23(2):115-8. PubMed ID: 12166592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.